Skip to main content
Healthcare

STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy

STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy

Feed excerpt — reported by STAT News

Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, Zolgensma.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.